[Absolutely not true and relatively true about risk reduction].
Skolbekken
John-Arne
JA
Psykologisk institutt Norges teknisk-naturvitenskapelige universitet 7491 Trondheim. johnas@svt.ntnu.no
Forsmo
Siri
S
D000329:Advertising; D004346:Drug Information Services; D004965:Estrogen Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005598:Fractures, Spontaneous / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D016017:Odds Ratio; D015663:Osteoporosis, Postmenopausal / Q000150:complications; D020849:Raloxifene Hydrochloride / Q000008:administration & dosage / Q000009:adverse effects; D040242:Risk Reduction Behavior; D020246:Venous Thrombosis / Q000209:etiology
D004965:Estrogen Antagonists; D020849:Raloxifene Hydrochloride